Kellie S. Reynolds
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 10
- Antibiotics Pharmacokinetics and Efficacy 7
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 6
-
- Pharmacological Effects and Toxicity Studies 6
- Pharmaceutical studies and practices 6
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 10
- Antibiotics Pharmacokinetics and Efficacy 7
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 5
- SARS-CoV-2 and COVID-19 Research 3
- HIV/AIDS drug development and treatment 3
- Co-authors
- Shiew‐Mei HuangXiaoxiong WeiSoraya MadaniPing ZhaoLei ZhangJoseph A. GrilloYuzhuo PanChristian Wagner
- Journals
- The Journal of Clinical Pharmacology (8 papers)Clinical Pharmacology & Therapeutics (8 papers)Clinical Infectious Diseases (3 papers)
- Partner nations
- United StatesSwedenCanada
In The Last Decade
Kellie S. Reynolds
29 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 103
- Pharmacology 535
- Oncology 372
- Pediatrics, Perinatology and Child Health 216
- Pharmacology 183
- Infectious Diseases 141
Countries citing papers authored by Kellie S. Reynolds
This map shows the geographic impact of Kellie S. Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kellie S. Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kellie S. Reynolds more than expected).
Fields of papers citing papers by Kellie S. Reynolds
This network shows the impact of papers produced by Kellie S. Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kellie S. Reynolds. The network helps show where Kellie S. Reynolds may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kellie S. Reynolds, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 13 | |
| 3 | 2021 | 2 | |
| 4 | 2021 | 16 | |
| 5 | 2021 | 6 | |
| 6 | 2021 | 5 | |
| 7 | 2020 | 7 | |
| 8 | 2020 | 14 | |
| 9 | 2018 | 14 | |
| 10 | 2017 | 47 | |
| 11 | 2017 | 61 | |
| 12 | 2014 | 35 | |
| 13 | 2014 | 119 | |
| 14 | 2012 | 80 | |
| 15 | 2010 | 94 | |
| 16 | 2009 | 70 | |
| 17 | 2008 | 9 | |
| 18 | 2002 | 266 | |
| 19 | 1999 | 53 | |
| 20 | 1998 | 13 |
About Kellie S. Reynolds
Kellie S. Reynolds is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health, Infectious Diseases, Pharmacology and Molecular Medicine, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Drug Transport and Resistance Mechanisms (6 papers), Pharmacological Effects and Toxicity Studies (6 papers), Pharmaceutical studies and practices (6 papers), COVID-19 Clinical Research Studies (5 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Pharmacology (535 citations), Oncology (372 citations), Pediatrics, Perinatology and Child Health (216 citations), Pharmacology (183 citations) and Infectious Diseases (141 citations). Kellie S. Reynolds has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Shiew‐Mei Huang, Xiaoxiong Wei, Soraya Madani, Ping Zhao, Ping Zhao, Lei Zhang, Lei Zhang, Joseph A. Grillo, Yuzhuo Pan and Christian Wagner. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Clinical Infectious Diseases, Journal of Pharmaceutical Sciences and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.